Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this ...
Cancer tumorigenesis is fundamentally driven by the profound dysregulation of gene regulatory networks (GRNs) and complex epigenetic alterations. With the ...
Q1 2026 Earnings Call April 28, 2026 3:00 AM EDTCompany ParticipantsFredrik Dalborg - President & CEOChristina Rubenhag ...
Scientists have developed a way to turn the body's own immune cells into cancer-fighting agents—without removing them from ...
The FDA has launched two proof-of-concept cancer trials to test real-time safety data monitoring and explore AI-assisted trial design. One AstraZeneca study has already validated a live data pipeline, ...
A recent review shows that proteomics-driven multi-omics integration reveals tumor heterogeneity and functional regulatory ...
Benjamin tenOever harnesses microRNA circuits and viruses to advance xenotransplantation and develop treatments for rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results